Comprehensive miRNA profiling of surgically staged endometrial cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20400061.
- Also identified by DOI 10.1016/j.ajog.2010.02.051 and PMC identifier 4278076.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We sought to determine a microRNA (miRNA) profile of surgically staged endometrial cancers. RNA was extracted from archival primary endometrial cancers, and an miRNA profile was established using a microarray and confirmed with real-time polymerase chain reaction. Targets of differentially expressed miRNAs were explored using real-time polymerase chain reaction and Western blot in endometrial cell lines. Endometrial cancer has an miRNA profile distinct from normal endometrium, even in patients with stage IA grade 1 tumors. This miRNA cancer profile was able to correctly assign a specimen as a malignancy with a sensitivity of 92%. Overexpressed miRNAs were predicted to target PTEN, and transfection of cell lines with these miRNAs led to down-regulation of PTEN expression. In advanced disease, an miRNA pattern distinct from early-stage disease was seen, and overexpression of mir-199c predicted improved cancer survival in this population. Endometrial cancer has a distinct miRNA profile, and miRNAs can be used as a predictive biomarker.
Medical subject headings
- Adenocarcinoma
- Endometrial Neoplasms
- Gene Expression Profiling
- MicroRNAs